INmune Bio Inc.

07/12/2020 | Press release | Distributed by Public on 07/12/2020 01:29

INmune Bio, Inc. to Announce Interim Data from Phase Ib Clinical Study of XPro1595 in Patients with Alzheimer’s Disease Prior to Start of AAIC 2020